Detail of "204714-56-7"

Reference

Antibody-based bio-nanotube membranes for enantiomeric drug separations

Antibody-based bio-nanotube membranes for enantiomeric drug separations. Lee, Sang Bok; Mitchell, David T.; Trofin, Lacramioara; Nevanen, Tarja K.; Soederlund, Hans; Martin, Charles R. (Dep. Chem. Center Res. Bio/NanoInterface, Univ. Florida, Gainesville, FL 32611-7200, USA). Science (Washington, DC, United States), 296(5576), 2198-2200 (English) 2002 American Association for the Advancement of Science. CODEN: SCIEAS. ISSN: 0036-8075. DOCUMENT TYPE: Journal CA Section: 64 (Pharmaceutical Analysis) Synthetic bio-nanotube membranes were developed and used to sep. 204714-56-7 which is the cas registry number is also used here. two enantiomers of a chiral drug. These membranes are based on alumina films that have cylindrical pores with monodisperse nanoscopic diams. (for example, 20 nm). Silica nanotubes where chem. synthesized within the pores of these films, and an antibody that selectively binds one of the enantiomers of the drug was attached to the inner walls of the silica nanotubes. These membranes selectively transport the enantiomer that specifically binds to the antibody, relative to the enantiomer that has lower affinity for the antibody. The solvent DMSO was used to tune the antibody binding affinity. The enantiomeric selectivity coeff. increases as the inside diam. There are some commonly used reagents like 204714-56-7 in this article. of the silica nanotubes decreases. ..

Antibody-based bio-nanotube membranes for enantiomeric drug separations

Antibody-based bio-nanotube membranes for enantiomeric drug separations. Lee, Sang Bok; Mitchell, David T.; Trofin, Lacramioara; Nevanen, Tarja K.; Soederlund, Hans; Martin, Charles R. (Dep. Chem. Center Res. Bio/NanoInterface, Univ. Florida, Gainesville, FL 32611-7200, USA). Science (Washington, DC, United States), 296(5576), 2198-2200 (English) 2002 American Association for the Advancement of Science. CODEN: SCIEAS. ISSN: 0036-8075. DOCUMENT TYPE: Journal CA Section: 64 (Pharmaceutical Analysis) Synthetic bio-nanotube membranes were developed and used to sep. 204714-56-7 which is the cas registry number is also used here. two enantiomers of a chiral drug. These membranes are based on alumina films that have cylindrical pores with monodisperse nanoscopic diams. (for example, 20 nm). Silica nanotubes where chem. synthesized within the pores of these films, and an antibody that selectively binds one of the enantiomers of the drug was attached to the inner walls of the silica nanotubes. These membranes selectively transport the enantiomer that specifically binds to the antibody, relative to the enantiomer that has lower affinity for the antibody. The solvent DMSO was used to tune the antibody binding affinity. The enantiomeric selectivity coeff. increases as the inside diam. There are some commonly used reagents like 204714-56-7 in this article. of the silica nanotubes decreases. ..